These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6375756)

  • 1. Effect of expectorants on relaxation behavior of sputum viscoelasticity in vivo.
    Shimura S; Okubo T; Maeda S; Aoki T; Tomioka M; Shindo Y; Takishima T; Umeya K
    Biorheology; 1983; 20(5):677-83. PubMed ID: 6375756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of mucolytic agents and stirring on sputum viscoelasticity.
    Takishima T; Sato S; Aoki T; Maeda S
    Tohoku J Exp Med; 1980 Jun; 131(2):103-17. PubMed ID: 7404580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency distribution of viscoelastic properties of sputum studied by the raised cosine pulse method: the effects of mucolytic agents.
    Okubo T; Shimura S; Takishima T; Otubo Y; Umeya K
    Biorheology; 1983; 20(2):231-8. PubMed ID: 6871437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of various expectorants on sputum viscoelasticity in vivo (author's transl)].
    Shimura S; Sato S; Aoki T; Takishima T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Mar; 18(3):161-70. PubMed ID: 7392320
    [No Abstract]   [Full Text] [Related]  

  • 5. A new method for evaluating mucolytic expectorant activity and its application. II. Application to two proteolytic enzymes, serratiopeptidase and seaprose.
    Kasé Y; Seo H; Oyama Y; Sakata M; Tomoda K; Takahama K; Hitoshi T; Okano Y; Miyata T
    Arzneimittelforschung; 1982; 32(4):374-8. PubMed ID: 7049188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sputum and expectorants].
    Korsgaard B; Pedersen JT
    Ugeskr Laeger; 1976 Sep; 138(39):2355-61. PubMed ID: 9719
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro.
    Grange JM; Snell NJ
    J Ethnopharmacol; 1996 Jan; 50(1):49-53. PubMed ID: 8778507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ambroxol and bromhexine as mucolytics for enhanced diffusion of furaltadone into tracheobronchial secretions in broilers.
    Sumano H; Gracia I; Capistrán A; Meade G; Rivero A; Ruiz-Ramírez L
    Br Poult Sci; 1995 Jul; 36(3):503-7. PubMed ID: 7583380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitussives and expectorants-a review (author's transl)].
    Petrin A; Schmidt R
    Schweiz Rundsch Med Prax; 1974 Jan; 63(2):30-6. PubMed ID: 4605508
    [No Abstract]   [Full Text] [Related]  

  • 10. The antioxidative activity of the mucoregulatory agents: ambroxol, bromhexine and N-acetyl-L-cysteine. A pulse radiolysis study.
    Felix K; Pairet M; Zimmermann R
    Life Sci; 1996; 59(14):1141-7. PubMed ID: 8831801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of lung levels of antibiotics by ambroxol and bromhexine.
    Deretic V; Timmins GS
    Expert Opin Drug Metab Toxicol; 2019 Mar; 15(3):213-218. PubMed ID: 30721101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro evaluation of mucolytic activities of some expectorants using porcine gastric mucin].
    Misawa M; Imamura N
    Nihon Yakurigaku Zasshi; 1988 Oct; 92(4):263-70. PubMed ID: 2468589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative histochemical study of the mechanism of action of 2 synthetic mucolytic agents, NA 872 and NA 274].
    Pesce Delfino V; Ricco R
    Pathologica; 1981; 73(1027):785-91. PubMed ID: 7342034
    [No Abstract]   [Full Text] [Related]  

  • 14. The mucolytic agent bromhexine (bisolvon) in chronic lung disease. A double-blind crossover trial.
    Cobbin DM; Elliott FM; Rebuck AS
    Aust N Z J Med; 1971 May; 1(2):137-40. PubMed ID: 4935896
    [No Abstract]   [Full Text] [Related]  

  • 15. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections.
    Hoffer-Schaefer A; Rozycki HJ; Yopp MA; Rubin BK
    Respir Care; 2014 May; 59(5):631-6. PubMed ID: 24003241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucolytic agents and mucociliary activity.
    Gunnarsson M; Hybbinette JC; Mercke U
    Rhinology; 1984 Dec; 22(4):223-31. PubMed ID: 6151739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M; Dasgupta B; Tomkiewicz RP; Brown NE
    Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Varidase buccal tablets on the sputum.
    Nagaoka S; Yamanaka E; Nakazawa Y; Katano F
    Clin Ther; 1980; 3(2):137-42. PubMed ID: 7448844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the lungs: Exploring diverse applications of bromhexine and ambroxol.
    Ahmadi E; Afrooghe A; Soltani ZE; Elahi M; Shayan M; Ohadi MAD; Dehpour AR
    Life Sci; 2024 Sep; 353():122909. PubMed ID: 38997062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of expectorant agents].
    Galsanov Shch B
    Sov Med; 1987; (12):100-5. PubMed ID: 3328304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.